![Yuval Sagiv](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Yuval Sagiv worked at Kamada Ltd. as Director-Preclinical & New Products.
Worked at HealOr Ltd. as Head-Preclinical Development.
Worked at Nanocarry Therapeutics Ltd. as Vice President-Research & Development.
Worked at Vidac Pharma Holding Plc as Chief Technology Officer.
Completed a doctorate at the Weizmann Institute of Science.
| Companies | Position | End |
|---|---|---|
| KAMADA LTD. | Corporate Officer/Principal | - |
| VIDAC PHARMA HOLDING PLC | Chief Tech/Sci/R&D Officer | - |
Nanocarry Therapeutics Ltd.
 Nanocarry Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as a biotech and pharmaceutical company | Chief Tech/Sci/R&D Officer | - |
HealOr Ltd.
 HealOr Ltd. Pharmaceuticals: MajorHealth Technology Develops and commercializes proprietary biochemical regulatory therapeutics | Corporate Officer/Principal | - |
Active
Inactive
Listed companies
Private companies
| Private companies | 5 |
|---|---|
Weizmann Institute of Science
 Weizmann Institute of Science Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kamada Ltd.
 Kamada Ltd. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops and manufactures plasma-derived therapeutics products | Health Technology |
HealOr Ltd.
HealOr Ltd. Pharmaceuticals: MajorHealth Technology Develops and commercializes proprietary biochemical regulatory therapeutics | Health Technology |
Nanocarry Therapeutics Ltd.
Nanocarry Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as a biotech and pharmaceutical company | Commercial Services |
Vidac Pharma Holding Plc
 Vidac Pharma Holding Plc BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company | Health Technology |
Select your edition
All financial news and data tailored to specific country editions
